Revvity Inc., founded in 2021 and headquartered in the tech hub of San Francisco, California, is a forward-thinking technology company focused on advancing scientific discovery and innovation through artificial intelligence and data analytics. The company offers cutting-edge solutions that streamline research and development processes for various industries, including pharmaceuticals, biotechnology, and materials science.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| PKI 1.88% 2026-07-19 EURRevvity Inc. | United States | 2026-07-19 | 1.875 | 2.32 |
| PKI 1.90% 2028-09-15 USDRevvity Inc. | United States | 2028-09-15 | 1.900 | 4.22 |
| PKI 2.25% 2031-09-15 USDRevvity Inc. | United States | 2031-09-15 | 2.250 | 4.71 |
| PKI 2.55% 2031-03-15 USDRevvity Inc. | United States | 2031-03-15 | 2.550 | 4.62 |
| PKI 3.30% 2029-09-15 USDRevvity Inc. | United States | 2029-09-15 | 3.300 | 4.35 |
| PKI 3.63% 2051-03-15 USDRevvity Inc. | United States | 2051-03-15 | 3.625 | 5.94 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Since its inception, Revvity Inc. has actively engaged in the bond market, issuing its first corporate bonds in 2022 to support its growth initiatives and R&D efforts. A notable issuance in mid-2023 raised $200 million to finance a strategic acquisition, reflecting confidence in its market potential. Currently, Revvity's bonds are yielding approximately 4.5%, aligning closely with industry averages, and feature unique sustainability-linked terms designed to appeal to socially responsible investors. Recent news highlights the company's commitment to enhancing liquidity through the introduction of convertible bonds in Q1 2024.